SCYNEXIS

SCYNEXIS, Inc. operates as a drug discovery and development company in the United States and internationally. It engages in drug discovery, development, and manufacturing projects in various areas, such as antibacterials, antifungals, antiparasitics, antivirals, carbohydrates, central nervous system, controlled substances, kinases, natural products, neglected diseases, nuclear hormones, nucleosides, oncology, ophthalmology, pain, and prodrugs. The company offers SCY-635, a drug that is used for ... patients who are chronically infected with genotype 1 hepatitis C virus. It also provides contract research solutions, including medicinal chemistry, discovery biology, ADMET-PK, bioanalysis and analytical chemistry, process chemistry, and cGMP manufacturing. The company delivers drug pipeline solutions to pharmaceutical, health, and life science partners. SCYNEXIS, Inc. was formerly known as SCYNEXIS Chemistry & Automation, Inc. and changed its name to SCYNEXIS, Inc. in June 2002. The company was incorporated in 1999 and is based in Durham, North Carolina.

#SimilarOrganizations #People #Financial #Event #Website #More

SCYNEXIS

Social Links:

Linkedin

Twitter

Facebook

X

Industry:

Biotechnology Health Care Manufacturing Pharmaceutical

Founded:

1999-01-01

Address:

Durham, North Carolina, United States

Country:

United States

Website Url:

http://www.scynexis.com

Total Employee:

51+

Status:

Active

Contact:

9195448697

Email Addresses:

[email protected]

Total Funding:

251.45 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Universal Analytics Apache

Similar Organizations

idera-pharmaceuticals-logo

Idera Pharmaceuticals

Idera Pharmaceuticals is engaged in the discovery and development of novel synthetic DNA and RNA-based drug candidates.

Current Advisors List

kent-gossett_image

Kent Gossett Board Observer @ SCYNEXIS
Board_observer

ann-f-hanham_image

Ann F. Hanham Board of Directors @ SCYNEXIS
Board_member

ed-penhoet_image

Ed Penhoet Board of Directors @ SCYNEXIS
Board_member

mounia-chaoui_image

Mounia Chaoui Independent Board Member @ SCYNEXIS
Board_member

Current Employees Featured

not_available_image

Samuel Hopkins
Samuel Hopkins Chief Scientific Officer @ SCYNEXIS
Chief Scientific Officer

charles-f-osborne_image

Charles F. Osborne
Charles F. Osborne Chief Financial Officer @ SCYNEXIS
Chief Financial Officer

christine-coyne_image

Christine Coyne
Christine Coyne Chief Commercial Officer @ SCYNEXIS
Chief Commercial Officer

not_available_image

Jim Maffezzoli
Jim Maffezzoli Vice President Marketing & Sales @ SCYNEXIS
Vice President Marketing & Sales
2020-06-01

david-angulo_image

David Angulo
David Angulo Chief Medical Officer @ SCYNEXIS
Chief Medical Officer
2015-06-01

eric-francois_image

Eric Francois
Eric Francois Chief Financial Officer @ SCYNEXIS
Chief Financial Officer
2015-11-01

marco-taglietti_image

Marco Taglietti
Marco Taglietti President and Chief Executive Officer @ SCYNEXIS
President and Chief Executive Officer

Founder

yves-j-ribeill_image

Yves J. Ribeill

Stock Details

Company's stock symbol is NASDAQ:SCYX

Investors List

silicon-valley-bank_image

Silicon Valley Bank

Silicon Valley Bank investment in Post-IPO Debt - SCYNEXIS

herculescapital_image

Hercules Capital

Hercules Capital investment in Post-IPO Debt - SCYNEXIS

armentum-partners_image

Armentum Partners

Armentum Partners investment in Debt Financing - SCYNEXIS

Key Employee Changes

Date	New article
2020-06-02	SCYNEXIS Strengthens Leadership Team with Appointment of Jim Maffezzoli as Vice President of Marketing and Sales

Official Site Inspections

http://www.scynexis.com Semrush global rank: 1.31 M Semrush visits lastest month: 22.46 K

Host Informations
Whois Informations

Loading ...

More informations about "SCYNEXIS" on Search Engine